Candriam Equities L Biotechnology, R - Capitalisation
WKN A2DHUX | ISIN LU0942225912 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | CH0113817123 | Bellevue Biotech DT CHF | +0,34 % | +18,48 % | -0,11 |
|
| 2 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -2,74 % | +18,53 % | -0,27 |
|
| 3 | LU0942225912 | Candriam Equities L Biotechnology, R - Capitalisation | -2,96 % | +18,51 % | -0,29 |
|
| 4 | LU0317020203 | Candriam Equities L Biotechnology, V - Capitalisation | -3,07 % | +18,37 % | -0,29 |
|
| 5 | LU0133360163 | Candriam Equities L Biotechnology, I - Capitalisation | -3,17 % | +18,33 % | -0,30 |
|
| 73 | DE000DWS2UA1 | DWS ESG Biotech TFC | -15,07 % | +20,03 % | -0,87 |
|
| 74 | LU0959058974 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 | -14,74 % | +19,63 % | -0,87 |
|
| 75 | LU1991432631 | UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK | -17,13 % | +20,73 % | -0,94 |
|
| 76 | DE000A3DCA95 | BIT Biotech Opportunities S | -32,28 % | +30,22 % | -1,14 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -32,35 % | +30,21 % | -1,15 |
|